Avanos Medical (AVNS) Scheduled to Post Quarterly Earnings on Thursday

Avanos Medical (NYSE:AVNS - Get Free Report) is scheduled to post its quarterly earnings results on Thursday, May 2nd. Analysts expect Avanos Medical to post earnings of $0.21 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS.Individual that wish to register for the company's earnings conference call can do so using this link.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.01). Avanos Medical had a negative net margin of 8.76% and a positive return on equity of 4.25%. The firm had revenue of $173.30 million during the quarter, compared to the consensus estimate of $170.43 million. During the same period last year, the business earned $0.60 EPS. The business's revenue was down 4.6% on a year-over-year basis. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Stock Performance

Shares of AVNS traded up $0.25 during midday trading on Friday, reaching $18.10. The stock had a trading volume of 132,680 shares, compared to its average volume of 277,832. The firm has a 50 day simple moving average of $19.24 and a 200-day simple moving average of $19.91. Avanos Medical has a one year low of $17.24 and a one year high of $30.28. The firm has a market cap of $836.22 million, a PE ratio of -13.71 and a beta of 0.96. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research report on Tuesday, March 19th.

Insider Buying and Selling

In related news, CFO Michael Greiner sold 8,000 shares of Avanos Medical stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $19.12, for a total transaction of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company's stock, valued at approximately $2,896,584.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 2.90% of the stock is currently owned by insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.